Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Moving Toward Excellence in Pediatric Physical Therapy Education: A Scoping Review.

Anderson DK, Furze JA, Moore JG.

Pediatr Phys Ther. 2019 Jan;31(1):95-113. doi: 10.1097/PEP.0000000000000549. Review.

PMID:
30507855
2.

Clinical narratives in residency education: Exploration of the learning process.

Furze JA, Greenfield BH, Barr JB, Geist K, Gale J, Jensen GM.

Physiother Theory Pract. 2018 May 15:1-16. doi: 10.1080/09593985.2018.1472686. [Epub ahead of print]

PMID:
29764267
3.

Resistance and resilience of root fungal communities to water limitation in a temperate agroecosystem.

Furze JR, Martin AR, Nasielski J, Thevathasan NV, Gordon AM, Isaac ME.

Ecol Evol. 2017 Apr 5;7(10):3443-3454. doi: 10.1002/ece3.2900. eCollection 2017 May.

4.

Clinical Reasoning: Survey of Teaching Methods, Integration, and Assessment in Entry-Level Physical Therapist Academic Education.

Christensen N, Black L, Furze J, Huhn K, Vendrely A, Wainwright S.

Phys Ther. 2017 Feb 1;97(2):175-186. doi: 10.2522/ptj.20150320.

PMID:
27609900
5.

Physical Therapy Residency and Fellowship Education: Reflections on the Past, Present, and Future.

Furze JA, Tichenor CJ, Fisher BE, Jensen GM, Rapport MJ.

Phys Ther. 2016 Jul;96(7):949-60. doi: 10.2522/ptj.20150473. Epub 2015 Dec 17.

PMID:
26678444
6.

Connecting Classroom, Clinic, and Context: Clinical Reasoning Strategies for Clinical Instructors and Academic Faculty.

Furze J, Kenyon LK, Jensen GM.

Pediatr Phys Ther. 2015 Winter;27(4):368-75. doi: 10.1097/PEP.0000000000000185.

PMID:
26397080
7.

Experiential Learning With Children: An Essential Component of Professional Physical Therapy Education.

Schreiber J, Moerchen VA, Rapport MJ, Martin K, Furze J, Lundeen H, Pelletier E.

Pediatr Phys Ther. 2015 Winter;27(4):356-67. doi: 10.1097/PEP.0000000000000195.

PMID:
26397079
8.

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.

Spencer AJ, Furze J, Honeycutt JD, Calvert A, Saurya S, Colloca S, Wyllie DH, Gilbert SC, Bregu M, Cottingham MG, Hill AV.

PLoS One. 2014 Aug 20;9(8):e105520. doi: 10.1371/journal.pone.0105520. eCollection 2014.

9.

Essential competencies in entry-level pediatric physical therapy education.

Rapport MJ, Furze J, Martin K, Schreiber J, Dannemiller LA, Dibiasio PA, Moerchen VA.

Pediatr Phys Ther. 2014 Spring;26(1):7-18. doi: 10.1097/PEP.0000000000000003.

PMID:
24356312
10.

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.

Warimwe GM, Lorenzo G, Lopez-Gil E, Reyes-Sandoval A, Cottingham MG, Spencer AJ, Collins KA, Dicks MD, Milicic A, Lall A, Furze J, Turner AV, Hill AV, Brun A, Gilbert SC.

Virol J. 2013 Dec 5;10:349. doi: 10.1186/1743-422X-10-349.

11.

Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.

Douglas AD, Williams AR, Knuepfer E, Illingworth JJ, Furze JM, Crosnier C, Choudhary P, Bustamante LY, Zakutansky SE, Awuah DK, Alanine DG, Theron M, Worth A, Shimkets R, Rayner JC, Holder AA, Wright GJ, Draper SJ.

J Immunol. 2014 Jan 1;192(1):245-58. doi: 10.4049/jimmunol.1302045. Epub 2013 Nov 29.

12.

Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.

Williams AR, Douglas AD, Miura K, Illingworth JJ, Choudhary P, Murungi LM, Furze JM, Diouf A, Miotto O, Crosnier C, Wright GJ, Kwiatkowski DP, Fairhurst RM, Long CA, Draper SJ.

PLoS Pathog. 2012;8(11):e1002991. doi: 10.1371/journal.ppat.1002991. Epub 2012 Nov 8.

13.

Reflections from an interprofessional education experience: evidence for the core competencies for interprofessional collaborative practice.

Doll J, Packard K, Furze J, Huggett K, Jensen G, Jorgensen D, Wilken M, Chelal H, Maio A.

J Interprof Care. 2013 Mar;27(2):194-6. doi: 10.3109/13561820.2012.729106. Epub 2012 Oct 10.

PMID:
23050941
14.

Describing the clinical reasoning process: application of a model of enablement to a pediatric case.

Furze J, Nelson K, O'Hare M, Ortner A, Threlkeld AJ, Jensen GM.

Physiother Theory Pract. 2013 Apr;29(3):222-31. doi: 10.3109/09593985.2012.727204. Epub 2012 Oct 4.

PMID:
23035766
15.

Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates.

Spencer AJ, Hill F, Honeycutt JD, Cottingham MG, Bregu M, Rollier CS, Furze J, Draper SJ, Søgaard KC, Gilbert SC, Wyllie DH, Hill AV.

PLoS One. 2012;7(3):e33555. doi: 10.1371/journal.pone.0033555. Epub 2012 Mar 28.

16.

Student perceptions of a community engagement experience: exploration of reflections on social responsibility and professional formation.

Furze J, Black L, Peck K, Jensen GM.

Physiother Theory Pract. 2011 Aug;27(6):411-21. doi: 10.3109/09593985.2010.516479. Epub 2010 Oct 14.

PMID:
20946070
17.

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.

Alcock R, Cottingham MG, Rollier CS, Furze J, De Costa SD, Hanlon M, Spencer AJ, Honeycutt JD, Wyllie DH, Gilbert SC, Bregu M, Hill AV.

Sci Transl Med. 2010 Feb 17;2(19):19ra12. doi: 10.1126/scitranslmed.3000490.

18.

Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccines.

Larsen KC, Spencer AJ, Goodman AL, Gilchrist A, Furze J, Rollier CS, Kiss-Toth E, Gilbert SC, Bregu M, Soilleux EJ, Hill AV, Wyllie DH.

Vaccine. 2009 Sep 18;27(41):5589-98. doi: 10.1016/j.vaccine.2009.07.025. Epub 2009 Jul 29.

PMID:
19646407
20.

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).

Cottingham MG, Andersen RF, Spencer AJ, Saurya S, Furze J, Hill AV, Gilbert SC.

PLoS One. 2008 Feb 20;3(2):e1638. doi: 10.1371/journal.pone.0001638. Erratum in: PLoS One. 2011;6(2). doi:10.1371/annotation/2b1d4029-f72a-4fa9-9776-20e4073f650e.

21.

Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches.

Wu SJ, Schmidt A, Beil EJ, Day ND, Branigan PJ, Liu C, Gutshall LL, Palomo C, Furze J, Taylor G, Melero JA, Tsui P, Del Vecchio AM, Kruszynski M.

J Gen Virol. 2007 Oct;88(Pt 10):2719-23.

PMID:
17872524
23.

Phosphorylcholine-based polymer coatings for stent drug delivery.

Lewis AL, Vick TA, Collias AC, Hughes LG, Palmer RR, Leppard SW, Furze JD, Taylor AS, Stratford PW.

J Mater Sci Mater Med. 2001 Oct-Dec;12(10-12):865-70.

PMID:
15348331
24.
25.

Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes.

Gaddum RM, Cook RS, Furze JM, Ellis SA, Taylor G.

Immunology. 2003 Feb;108(2):220-9.

26.

Long-term stability of a coronary stent coating post-implantation.

Lewis AL, Furze JD, Small S, Robertson JD, Higgins BJ, Taylor S, Ricci DR.

J Biomed Mater Res. 2002;63(6):699-705.

PMID:
12418013
27.

B1 integrin activation inhibits in vitro tube formation: effects on cell migration, vacuole coalescence and lumen formation.

Gamble J, Meyer G, Noack L, Furze J, Matthias L, Kovach N, Harlant J, Vadas M.

Endothelium. 1999;7(1):23-34.

PMID:
10599558
28.

Cloning, characterization, and chromosomal location of a novel human K+-Cl- cotransporter.

Hiki K, D'Andrea RJ, Furze J, Crawford J, Woollatt E, Sutherland GR, Vadas MA, Gamble JR.

J Biol Chem. 1999 Apr 9;274(15):10661-7.

29.
31.

Novel cytokine-independent induction of endothelial adhesion molecules regulated by platelet/endothelial cell adhesion molecule (CD31).

Litwin M, Clark K, Noack L, Furze J, Berndt M, Albelda S, Vadas M, Gamble J.

J Cell Biol. 1997 Oct 6;139(1):219-28.

32.
33.

Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus.

Langedijk JP, Meloen RH, Taylor G, Furze JM, van Oirschot JT.

J Virol. 1997 May;71(5):4055-61.

34.

Antigenically distinct G glycoproteins of BRSV strains share a high degree of genetic homogeneity.

Furze JM, Roberts SR, Wertz GW, Taylor G.

Virology. 1997 Apr 28;231(1):48-58.

35.

Subgrouping of bovine respiratory syncytial virus strains detected in lung tissue.

Schrijver RS, Daus F, Kramps JA, Langedijk JP, Buijs R, Middel WG, Taylor G, Furze J, Huyben MW, van Oirschot JT.

Vet Microbiol. 1996 Dec;53(3-4):253-60.

PMID:
9008336
36.

Molecular cloning and functional identification of a plant ornithine decarboxylase cDNA.

Michael AJ, Furze JM, Rhodes MJ, Burtin D.

Biochem J. 1996 Feb 15;314 ( Pt 1):241-8.

37.

Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves.

Taylor G, Thomas LH, Wyld SG, Furze J, Sopp P, Howard CJ.

J Virol. 1995 Nov;69(11):6658-64.

38.

Isolation and expression pattern of a cDNA encoding a cathepsin B-like protease from Nicotiana rustica.

Lidgett AJ, Moran M, Wong KA, Furze J, Rhodes MJ, Hamill JD.

Plant Mol Biol. 1995 Oct;29(2):379-84.

PMID:
7579187
40.

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.

Vitiello A, Ishioka G, Grey HM, Rose R, Farness P, LaFond R, Yuan L, Chisari FV, Furze J, Bartholomeuz R, et al.

J Clin Invest. 1995 Jan;95(1):341-9.

41.

Antigenic heterogeneity of the attachment protein of bovine respiratory syncytial virus.

Furze J, Wertz G, Lerch R, Taylor G.

J Gen Virol. 1994 Feb;75 ( Pt 2):363-70.

PMID:
8113757
42.

Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.

Arbiza J, Taylor G, López JA, Furze J, Wyld S, Whyte P, Stott EJ, Wertz G, Sullender W, Trudel M, et al.

J Gen Virol. 1992 Sep;73 ( Pt 9):2225-34.

PMID:
1383404
43.

Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies.

Taylor G, Stott EJ, Furze J, Ford J, Sopp P.

J Gen Virol. 1992 Sep;73 ( Pt 9):2217-23.

PMID:
1383403
44.

Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules.

Sette A, Vitiello A, Farness P, Furze J, Sidney J, Claverie JM, Grey HM, Chesnut R.

J Immunol. 1991 Dec 1;147(11):3893-900.

PMID:
1658152
45.

Humanised monoclonal antibody to respiratory syncytial virus.

Taylor G, Furze J, Tempest PR, Bremner P, Carr FJ, Harris WJ.

Lancet. 1991 Jun 8;337(8754):1411-2. No abstract available.

PMID:
1674780
46.

Abiotic factors elicit sesquiterpenoid phytoalexin production but not alkaloid production in transformed root cultures of Datura stramonium.

Furze JM, Rhodes MJ, Parr AJ, Robins RJ, Withehead IM, Threlfall DR.

Plant Cell Rep. 1991 Jun;10(3):111-4. doi: 10.1007/BF00232039.

PMID:
24221487
48.

Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo.

Tempest PR, Bremner P, Lambert M, Taylor G, Furze JM, Carr FJ, Harris WJ.

Biotechnology (N Y). 1991 Mar;9(3):266-71.

PMID:
1367535
49.

Over-expressing a yeast ornithine decarboxylase gene in transgenic roots of Nicotiana rustica can lead to enhanced nicotine accumulation.

Hamill JD, Robins RJ, Parr AJ, Evans DM, Furze JM, Rhodes MJ.

Plant Mol Biol. 1990 Jul;15(1):27-38.

PMID:
2103440
50.

Production and characterization of bovine monoclonal antibodies to respiratory syncytial virus.

Kennedy HE, Jones BV, Tucker EM, Ford NJ, Clarke SW, Furze J, Thomas LH, Stott EJ.

J Gen Virol. 1988 Dec;69 ( Pt 12):3023-32.

PMID:
3199102

Supplemental Content

Support Center